JAK2 V617F, Exon 12 and Other Non-V617F Mutation Analysis (JAK2 NGS)
eDH Procedure Code(s)
LAB4321 JAK2 V617F, Exon12, and Other Non-V617F Mut
Test Information
Clinical indication: Erythrocytosis and specific concern for polycythemia vera; This Next Generation Sequencing based assay is intended to detect JAK2 p.V617F and other non-V617F Mutations in JAK2 exons 12, 13, 14, and 15.
Order Questions
| LAB4321 JAK2 V617F, Exon12, and Other Non-V617F Mut |
|
Specimen Information
| Specimen Type | Specimen Source | Acceptable Containers | Minimum Test Volume (mL) | |
|---|---|---|---|---|
| Blood | Blood, Venous | Lav4-R | 1.0 | |
| Blood | Blood, Venous | Lav6-R | 1.0 | |
Shipping and Handling
Processing Instructions: N/ATransport Temperature: Refrigerated at 4°C
Transport Instructions: N/A
Specimen Stability Unprocessed
Unprocessed: Refrigerated at 4°C for 7 days
Specimen Stability Post Processing
Ambient: N/A
Refrigerate: N/A
Frozen: N/A
Test Components
| Component | LOINC Code |
|---|---|
| NGS REPORT STATUS | 62364-5 |
Turnaround Time (TAT)
15 Days
CPT Code(s)
81279
Performing Lab Section
Molecular Pathology
Performing Lab(s)
Dartmouth Hitchcock Medical Center Laboratory (MHMH)